Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza.

Patterson, Dustin P; Rynda-Apple, Agnieszka; Harmsen, Ann L; Harmsen, Allen G; Douglas, Trevor

Patterson, Dustin P; Rynda-Apple, Agnieszka; Harmsen, Ann L; Harmsen, Allen G; Douglas, Trevor.

Affiliation

Patterson DP; Department of Chemistry and Biochemistry, Center for Bio-Inspired Nanomaterials, Montana State University, Bozeman, Montana 59717, United States.

ACS Nano ; 7(4): 3036-44, 2013 Apr 23.

Article in En | MEDLINE | ID: mdl-23540530

Subject(s)

Histocompatibility Antigens Class II/administration & dosage; Nanoparticles/administration & dosage; Nanoparticles/chemistry; Orthomyxoviridae Infections/immunology; Orthomyxoviridae Infections/prevention & control; Vaccines, Virus-Like Particle/administration & dosage; Animals; Biomimetic Materials/administration & dosage; Biomimetic Materials/chemical synthesis; Histocompatibility Antigens Class II/chemistry; Influenza A Virus, H1N1 Subtype; Mice; Treatment Outcome; Vaccines, Virus-Like Particle/chemistry; Vaccines, Virus-Like Particle/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Histocompatibility Antigens Class II / Orthomyxoviridae Infections / Nanoparticles / Vaccines, Virus-Like Particle Limits: Animals Language: En Journal: ACS Nano Year: 2013 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google